5Y News | Zai Ling Bio Completes Nearly RMB 600 Million Series C Financing
The funding will go toward global clinical development, pipeline expansion, and technology platform upgrades.
The funding will go toward global clinical development, pipeline expansion, and technology platform upgrades.
Breaking the GUI OS paradigm, the AI-native era demands a fundamentally new "human-like cognition" operating system.
A global leader in innovative tumor immunotherapy
late-stage clinical biotech company
The only embodied artificial intelligence company in China to have received investment from all three major tech giants — Meituan, Alibaba, and ByteDance
The funds will be primarily used for product iteration of general-purpose home robots and enhancements to core algorithms and system capabilities.
Counselor Vitality
If Kimi ever goes public, will the bell-ringing photo look very different?
Never Stop Moving, Witnessing Growth
From founding to IPO in just four years.